Help improve lives.
Join a CMV vaccine study.

The Need for Cytomegalovirus (CMV) Vaccine Research

Cytomegalovirus (CMV) is the most common infectious cause of birth defects in the U.S. Congenital CMV does not usually cause illness or symptoms in babies, but about 1 out of 5 babies with congenital CMV will experience symptoms or long-term health problems. CMV infection in utero can seriously impact development of a fetus, resulting in hearing loss, developmental and motor delay, vision loss, microcephaly (small head), or seizures. When a pregnant woman is infected with CMV during pregnancy, the virus van pass through the placenta and infect the baby during pregnancy.

There are currently no approved CMV vaccines. However, some promising CMV vaccine candidates are in clinical trials. A safe and effective vaccine could reduce the number of birth defects in newborns and mono hospitalizations by preventing a significant number of infections.

Meridian has supported vaccine studies for more than a decade, and frequently conducts CMV vaccine studies for children, adults, and even pregnant women.

How to Participate in a CMV Vaccine Trial

Meridian has research sites nationwide that are conducting research studies in a wide range of therapeutic areas. New studies are added every week. You can help fight CMV by joining a study at Meridian.

Beyond helping advance medicine, you may also:

• Get care from a local doctor at no cost
• Receive study-related medical exams at no cost
• Get paid for participating (amounts differ for each study)

The best way to find out which CMV studies are currently enrolling patients in your community and determine your eligibility is to complete the form on this page or call Meridian to speak with an enrollment specialist.